ADvantage Therapeutics, Inc.

New Filing
CIK: 0001869338·Other Health Care·DELAWARE·Filed: Jul 12, 2023
Total Offering

$25,449,956

Amount Sold

$10,224,998

Investors

17

First Sale

Jun 28, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Agustin Fernandez Santana III
Related Person
Jeffrey B. Madden
Related Person
Frank Mattner
Related Person
Walter Schmidt
Related Person
David Buchsbaum
Related Person
James O'Neill
Related Person

Company

ADvantage Therapeutics, Inc.

195 NW 40th Street

MIAMI, FL, 33127

3058469027

SEC Filing

0001869338-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free